Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Bausch Health Companies Inc |
6/02 | 5,880 USD
+2,62% |
+2,62% |
|
Baxter |
6/02 | 21,730 USD
-0,18% |
-0,18% |
Bayer AG |
6/02 | 45,800 EUR
+2,20% |
+2,20% |
|
Beam Therapeutics Inc |
6/02 | 26,520 USD
+7,24% |
+7,24% |
|
Becton, Dickinson And Co. |
6/02 | 210,020 USD
+1,70% |
+1,70% |
|
BeiGene Ltd |
6/02 | 353,920 USD
+1,99% |
+1,99% |
|
Bellring Brands Inc |
6/02 | 19,520 USD
+0,21% |
+0,21% |
|
Benitec Biopharma Inc |
6/02 | 12,120 USD
+4,03% |
+4,03% |
Beximco Pharmaceuticals Limited - GDR - Reg S |
2/01 | 42,500 GBX
0,00% |
0,00% |
|
BeyondSpring Inc |
6/02 | 1,500 USD
-2,60% |
-2,60% |
|
Bicycle Therapeutics Plc |
6/02 | 5,660 USD
+6,59% |
+6,59% |
|
Bio-Path Holdings Inc |
6/02 | 0,059 USD
-1,50% |
-1,50% |
|
Bio-Rad Laboratories Inc. |
5/02 | 295,050 USD
0,00% |
0,00% |
|
Bio-Rad Laboratories Inc. |
6/02 | 301,500 USD
+0,65% |
+0,65% |
|
Bio-Techne Corp |
6/02 | 66,780 USD
+1,40% |
+1,40% |
|
BioCardia Inc. |
6/02 | 1,250 USD
+0,81% |
+0,81% |
|
Biocryst Pharmaceuticals Inc. |
6/02 | 6,380 USD
+2,24% |
+2,24% |
|
Biogen |
6/02 | 201,180 USD
+8,53% |
+8,53% |
|
Biohaven Ltd |
6/02 | 11,600 USD
+7,81% |
+7,81% |
|
Biolife Solutions Inc |
6/02 | 22,430 USD
+1,86% |
+1,86% |
|
Bioline Rx Ltd |
6/02 | 2,980 USD
+2,05% |
+2,05% |
|
Biomarin Pharmaceutical Inc. |
6/02 | 58,130 USD
+1,71% |
+1,71% |
|
Biomerica Inc. |
6/02 | 2,250 USD
-0,88% |
-0,88% |
Biomerieux |
6/02 | 94,800 EUR
-2,77% |
-2,77% |
|
BiomX Inc |
6/02 | 3,930 USD
-13,82% |
-13,82% |
|
Bionano Genomics Inc |
6/02 | 1,150 USD
+2,22% |
+2,22% |
|
BioNTech SE |
6/02 | 106,620 USD
+1,02% |
+1,02% |
|
Biophytis |
6/02 | 0,058 EUR
-3,01% |
-3,01% |
|
BioRestorative Therapies Inc |
6/02 | 1,040 USD
+1,96% |
+1,96% |
BioSenic |
6/02 | 0,002 EUR
0,00% |
0,00% |
Biosyent Inc |
6/02 | 12,800 CAD
-7,25% |
-7,25% |
|
Biosynex |
6/02 | 1,020 EUR
+9,68% |
+9,68% |
|
Biotest AG |
10/06 | 30,400 EUR
+7,04% |
+7,04% |
|
Biotest AG |
10/06 | 40,200 EUR
-4,74% |
-4,74% |
|
BioVie Inc |
6/02 | 1,130 USD
+6,60% |
+6,60% |
|
BioXcel Therapeutics Inc |
6/02 | 1,500 USD
+9,49% |
+9,49% |
|
Black Diamond Therapeutics Inc |
6/02 | 2,255 USD
+4,40% |
+4,40% |
|
Bluelinea SA |
6/02 | 0,480 EUR
-3,61% |
-3,61% |
|
Boiron |
6/02 | 29,500 EUR
0,00% |
0,00% |
|
Bone Biologics Corp |
6/02 | 1,400 USD
+2,56% |
+2,56% |
|
Boston Scientific Corp. |
6/02 | 76,270 USD
-1,76% |
-1,76% |
|
Boundless Bio Inc. |
6/02 | 1,160 USD
+6,42% |
+6,42% |
|
BRAIN Biotech AG |
6/02 | 2,240 EUR
+2,75% |
+2,75% |
|
Brainstorm Cell Therapeutics, Inc. |
6/02 | 0,580 USD
-0,60% |
-0,60% |
|
Brainsway Ltd |
6/02 | 21,780 USD
+4,06% |
+4,06% |
|
BriaCell Therapeutics Corp |
6/02 | 4,180 USD
+0,24% |
+0,24% |
|
BridgeBio Pharma Inc |
6/02 | 68,050 USD
+6,78% |
+6,78% |
|
Bristol-Myers Squibb Co. |
6/02 | 61,990 USD
+4,15% |
+4,15% |
|
Bruker Corp |
6/02 | 41,930 USD
+2,17% |
+2,17% |